| Literature DB >> 33100379 |
Siyamak Shahab1,2,3, Masoome Sheikhi4, Radwan Alnajjar5,6, Sultan Al Saud1, Maksim Khancheuski1, Aleksandra Strogova1.
Abstract
Atazanavir (ATZ) is an antiviral drug synthesized.ATZ is being investigated for potential application against the Coronavirus 2019-nCoV. To find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug ATZ which may work as an inhibitor for the Mpro of 2019-nCoV. In the present work, the first time the molecular structure of ATZ molecule has been studied using Density Functional Theory (CAMB3LYP/6-31G*) in solvent water. The electronic properties, atomic charges, MEP, NBO analysis, and excitation energies of ATZ have also been studied. The interaction of ATZ compound with the Coronavirus was performed by molecular docking studies.Entities:
Keywords: Atazanavir; Coronavirus 2019-nCoV; DFT; Electronic properties; Molecular docking
Year: 2020 PMID: 33100379 PMCID: PMC7568473 DOI: 10.1016/j.molstruc.2020.129461
Source DB: PubMed Journal: J Mol Struct ISSN: 0022-2860 Impact factor: 3.196
Fig. 1The obtained conformers with relative energies computed at PM6 in gas.
Fig. 2Optimized structure of the ATZ by CAMB3LYP/6-31G* method.
Selected optimized geometrical parameters (Bond lengths (Å) and Bond angles (°)) of the ATZ molecule.
| Bond | Bond lengths (Å) | Bond | Bond angles (Å) |
|---|---|---|---|
| N1-C2 | 1.468 | N1-C2-C5 | 115.22 |
| N1-N3 | 1.385 | N1-N3-C6 | 120.73 |
| N1-C4 | 1.469 | N1-C4-C18 | 109.03 |
| C2-C5 | 1.516 | N1-N3-H54 | 119.11 |
| N3-C6 | 1.349 | C2-N1-N3 | 112.79 |
| C4-C18 | 1.528 | C2-N1-C4 | 117.52 |
| C6-C7 | 1.529 | N3-N1-C4 | 114.97 |
| C6-O8 | 1.233 | N3-C6-C7 | 115.75 |
| C7-N9 | 1.454 | N3-C6-O8 | 123.09 |
| C7-C14 | 1.561 | C7-C6-O8 | 121.15 |
| C14-C15 | 1.534 | C7-N9-H58 | 117.11 |
| C14-C16 | 1.534 | C6-C7-C14 | 113.52 |
| C14-C17 | 1.533 | N9-C7-C14 | 112.77 |
| N9-C10 | 1.353 | C7-C14-C17 | 111.97 |
| C5-C41 | 1.398 | N9-C10-O11 | 112.87 |
| C5-C45 | 1.397 | N9-C10-O12 | 123.62 |
| C10-O11 | 1.342 | C10-O11-C13 | 116.13 |
| C10-O12 | 1.225 | O11-C10-O12 | 123.49 |
| O11-C13 | 1.433 | C15-C14-C17 | 109.52 |
| C18-C19 | 1.538 | C16-C14-C17 | 109.23 |
| C18-O20 | 1.418 | C18-O20-H73 | 109.20 |
| C19-N21 | 1.456 | C19-N21-C23 | 122.96 |
| C19-C22 | 1.533 | C19-N21-H74 | 119.20 |
| N21-C23 | 1.348 | C19-C22-C35 | 114.14 |
| C22-C35 | 1.511 | N21-C19-C22 | 110.94 |
| C23-O25 | 1.232 | N21-C23-O25 | 122.90 |
| C23-C24 | 1.537 | C22-C35-C36 | 120.84 |
| C24-N26 | 1.457 | C23-C24-N26 | 111.91 |
| C24-C27 | 1.561 | C23-C24-C27 | 103.68 |
| C27-C28 | 1.535 | C24-N26-H78 | 119.64 |
| C27-C29 | 1.536 | N26-C31-C32 | 112.22 |
| C27-C30 | 1.534 | N26-C31-O33 | 123.94 |
| N26-C31 | 1.357 | C28-C27-C30 | 108.85 |
| C31-O32 | 1.341 | C29-C27-C30 | 109.81 |
| C31-O33 | 1.224 | C31-O32-C34 | 116.31 |
| O32-C34 | 1.434 | O32-C31-O33 | 123.82 |
| C35-C36 | 1.395 | C35-C36-C37 | 121.03 |
| C35-C40 | 1.398 | C41-C42-C43 | 120.73 |
| C36-C37 | 1.393 | C42-C43-C44 | 118.23 |
| C37-C38 | 1.391 | C42-C43-C46 | 120.25 |
| C38-C39 | 1.394 | C43-C44-C45 | 120.87 |
| C39-C40 | 1.391 | C43-C46-N47 | 116.87 |
| N3-H54 | 1.016 | C44-C43-C46 | 121.49 |
| N9-H58 | 1.011 | C46-N47-C48 | 118.59 |
| N21-H74 | 1.011 | C48-C49-C50 | 117.90 |
| N26-H78 | 1.010 | C49-C50-C51 | 118.98 |
The calculated electronic properties of the ATZ.
| Property | CAMB3LYP |
|---|---|
| Electronic Energy | -2333.453 |
| DM (Debye) | 14.33 |
| Point Group | C1 |
| EHOMO (eV) | -7.9710 |
| ELUMO (eV) | -0.3906 |
| Eg (eV) | 7.5804 |
| 7.97 | |
| 0.39 | |
| 4.18 | |
| 3.79 | |
| -4.18 | |
| 2.30 | |
| 0.13 |
Fig. 3The shape of HOMO and LUMO orbitals and DOS plot of the molecule ATZ.
Fig. 4MEP map of the molecule ATZ.
The selected calculated Mulliken and NBO charges (e) of the ATZ.
| Atoms | NBO | Mulliken |
|---|---|---|
| N1 | -0.372 | -0.139 |
| N3 | -0.469 | -0.008 |
| N9 | -0.684 | -0.689 |
| N21 | -0.664 | -0.146 |
| N26 | -0.700 | -0.814 |
| N47 | -0.490 | -0.264 |
| O8 | -0.700 | -0.478 |
| O11 | -0.580 | -0.346 |
| O12 | -0.723 | -0.586 |
| O20 | -0.824 | -0.663 |
| O25 | -0.704 | -0.470 |
| O32 | -0.576 | -0.270 |
| O33 | -0.716 | -0.537 |
| C6 | 0.715 | -0.457 |
| C10 | 0.959 | 0.855 |
| C15 | -0.692 | -0.538 |
| C16 | -0.686 | -0.504 |
| C17 | -0.694 | -0.660 |
| C22 | -0.491 | -0.095 |
| C23 | 0.713 | -0.220 |
| C28 | -0.684 | -0.592 |
| C29 | -0.686 | -0.432 |
| C30 | -0.694 | -0.386 |
| C31 | 0.960 | 0.482 |
| H52 | 0.263 | 0.259 |
| H53 | 0.263 | 0.246 |
| H54 | 0.437 | 0.471 |
| H58 | 0.459 | 0.486 |
| H72 | 0.277 | 0.253 |
| H73 | 0.525 | 0.590 |
| H74 | 0.449 | 0.489 |
| H75 | 0.278 | 0.265 |
| H77 | 0.291 | 0.266 |
| H78 | 0.453 | 0.487 |
Fig. 5Mulliken andnatural charges distribution of the ATZ.
Significant donor–acceptor interactions and second order perturbation energies of the ATZ.
| Donor (i) | Occupancy | Acceptor (j) | Occupancy | E(2) | E(j)-E(i) | F(i, j) |
|---|---|---|---|---|---|---|
| σ(N3-C6) | 1.98979 | σ*(N1-C2) | 0.03037 | 1.18 | 1.35 | 0.036 |
| σ(C7-N9) | 1.98077 | σ*(C10-O12) | 0.29975 | 1.06 | 1.01 | 0.032 |
| σ(C14-C15) | 1.97710 | σ*(C16-H66) | 0.00655 | 1.92 | 1.19 | 0.043 |
| σ(N21-C23) | 1.98929 | σ*(C19-N21) | 0.02812 | 1.68 | 1.34 | 0.043 |
| σ(C31-O33) | 1.99190 | σ*(N26-C31) | 0.06423 | 1.32 | 1.59 | 0.041 |
| σ(C41-C42) | 1.97881 | σ*(C43-C46) | 0.03426 | 3.66 | 1.30 | 0.062 |
| π(C5-C45) | 1.64737 | π*(C41-C42) | 0.31237 | 28.63 | 0.036 | 0.092 |
| π*(C43-C44) | 0.35947 | 31.12 | 0.36 | 0.095 | ||
| π(C35-C36) | 1.65717 | π*C37-C38) | 0.33006 | 31.45 | 0.036 | 0.095 |
| π*(C39-C40) | 0.32465 | 29.00 | 0.36 | 0.092 | ||
| π(C37-C38) | 1.67086 | π*(C35-C36) | 0.33704 | 28.67 | 0.37 | 0.092 |
| π*(C39-C40) | 0.32465 | 30.63 | 0.36 | 0.094 | ||
| π(C39-C40) | 1.67400 | π*(C35-C36) | 0.33704 | 30.74 | 0.37 | 0.095 |
| π*(C37-C38) | 0.33006 | 29.15 | 0.36 | 0.092 | ||
| π(C41-C42) | 1.65951 | π*(C5-C45) | 0.35149 | 31.04 | 0.37 | 0.095 |
| π*(C43-C44) | 0.35947 | 29.31 | 0.36 | 0.093 | ||
| π(C43-C44) | 1.63676 | π*(C5-C45) | 0.35149 | 30.62 | 0.36 | 0.094 |
| π*(C41-C42) | 0.31237 | 29.15 | 0.36 | 0.093 | ||
| π*(C46-N47) | 0.42196 | 16.79 | 0.33 | 0.067 | ||
| π(C46-N47) | 1.70909 | π*(C48-C49) | 0.30173 | 37.89 | 0.41 | 0.112 |
| π*(C50-C51) | 0.29704 | 18.15 | 0.41 | 0.077 | ||
| π(C48-C49) | 1.63073 | π*(C46-N47) | 0.42196 | 26.27 | 0.34 | 0.085 |
| π*(C50-C51) | 0.29704 | 33.83 | 0.37 | 0.101 | ||
| π(C50-C51) | 1.64304 | π*(C46-N47) | 0.42196 | 42.21 | 0.34 | 0.109 |
| π*(C48-C49) | 0.30173 | 25.28 | 0.36 | 0.087 | ||
| π*(C46-N47) | 0.42196 | π*(C48-C49) | 0.30173 | 165.42 | 0.02 | 0.094 |
| π*(C50-C51) | 0.29704 | 171.64 | 0.03 | 0.100 | ||
| n1(N1) | 1.89493 | σ*(C2-C5) | 0.03299 | 8.71 | 0.82 | 0.077 |
| σ*(N3-H54) | 0.03212 | 9.55 | 0.82 | 0.081 | ||
| n1(N3) | 1.68960 | π*(C6-O8) | 0.29581 | 82.19 | 0.39 | 0.161 |
| n2(O8) | 1.87349 | σ*(N3-C6) | 0.07037 | 25.30 | 0.88 | 0.135 |
| σ*(C6-C7) | 0.06443 | 22.00 | 0.76 | 0.118 | ||
| n1(N9) | 1.73155 | σ*(C10-O12) | 0.29975 | 47.73 | 0.49 | 0.138 |
| n1(O11) | 1.95784 | π*(C10-O12) | 0.11541 | 9.11 | 1.12 | 0.092 |
| n2(O11) | 1.82707 | σ*(C10-O12) | 0.29975 | 32.51 | 0.57 | 0.126 |
| n2(O12) | 1.85596 | σ*(N9-C10) | 0.06299 | 24.61 | 0.86 | 0.133 |
| σ*(C10-O11) | 0.09572 | 36.98 | 0.75 | 0.151 | ||
| n1(N21) | 1.68253 | π*(C23-O25) | 0.28366 | 76.25 | 0.40 | 0.158 |
| n2(O25) | 1.88365 | σ*(N21-C23) | 0.06630 | 27.02 | 0.88 | 0.140 |
| σ*(C23-C24) | 0.07220 | 22.01 | 0.75 | 0.116 | ||
| n1(N26) | 1.74199 | π*(C31-O33) | 0.33447 | 59.38 | 0.42 | 0.144 |
| n1(O32) | 1.95858 | σ*(C31-O33) | 0.06865 | 10.65 | 1.20 | 0.102 |
| n2(O32) | 1.82199 | π*(C31-O33) | 0.33447 | 45.51 | 0.50 | 0.140 |
| n2(O33) | 1.85515 | σ*(N26-C31) | 0.06423 | 24.93 | 0.86 | 0.133 |
| σ*(C31-O32) | 0.09568 | 37.03 | 0.76 | 0.151 | ||
| n1(N47) | 1.92555 | σ*(C46-C51) | 0.03136 | 11.16 | 1.03 | 0.097 |
| σ*(C48-C49) | 0.02559 | 10.76 | 1.04 | 0.096 |
E(2) Energy of hyperconjucative interactions,
Energy difference between donor and acceptor i and j NBO orbitals,
F(i, j) is the Fock matrix element between i and j NBO orbitals.
Electronic absorption spectrum of the ATZ molecule calculated by CAM-B3LYP/6-31G* method.
| Excited State | Wavelength (nm) | Excitation Energy (Ev) | Configurations Composition (corresponding transition orbitals) | Oscillator Strength (f) |
|---|---|---|---|---|
| 253.70 | 4.88 | H→L (85%), H-2→L (2%), H→L+1 (3%) | 0.69 | |
| 202.55 | 6.12 | H-5→L (16%), H→L+3 (11%), H-9→L (7%), H-2→L+2 (2%), H-2→L+3 (2%), H-2→L+11 (9%), H-2→L+13 (9%), H→L+1 (8%), H→L+2 (7%) | 0.10 | |
| 196.94 | 6.29 | H-9→L (12%), H-5→L+3 (11%), H→L+2 (21%), H-13→L (5%), H-9→L+1 (3%), H-5→L (3%), H-5→L+1 (6%), H-5→L+2 (4%), H→L+3 (3%), H→L+7 (2%), H→L+8 (2%), H→L+20 (4%) | 0.11 | |
| 194.57 | 6.37 | H→L+2 (19%), H→L+7 (17%), H-13→L (5%), H-12→L (4%), H-9→L+1 (3%), H-5→L+1 (5%), H-5→L+2 (4%), H-5→L+3 (9%), H→L+1 (3%), H→L+3 (2%), H→L+4 (4%), H→L+16 (3%) | 0.12 | |
| 185.74 | 6.67 | H-9→L+1 (14%), H-5→L+1 (13%), H-13→L (8%), H-12→L (7%), H-12→L+1 (4%), H-5→L+3 (3%), H-2→L+2 (4%), H→L+1 (3%), H→L+3 (6%), H→L+4 (3%), H→L+13 (2%), H→L+20 (3%) | 0.40 | |
| 184.22 | 6.73 | H-3→L+2 (10%), H-3→L+4 (11%), H-3→L+6 (24%), H-1→L+6 (14%) H-3→L+3 (6%), H-3→L+7 (3%), H-3→L+9 (5%), H-2→L+2 (2%), H-1→L+4 (6%) | 0.39 |
*H-HOMO, L-LUMO
**In these table the transitions with f ≥ 0.1 are presented.
Fig. 6UV spectra of the ATZ molecule calculated by TD-CAMB3LYP/6-31G* method.
Fig. 7Interaction of Atazanavir with Coronavirus 2019-nCoV.
Fig. 8Docking hydrogen bonds interactions between the Atazanavir and Coronavirus 2019-nCoV.
Molecular docking energy data for mentioned ligand and hydrogen bonding.
| Protein | Bonded residues | ID | Hydrogen bond | Bond distance (Å) | Binding energy (kcal/mol) |
|---|---|---|---|---|---|
| 2019-nCoV | Tyr | 161 | 1 | 1.4390 | -5.1104 |
| 2019-nCoV | His | 163 | 1 | 1.2878 | -6.5378 |
| 2019-nCoV | Thr | 135 | 1 | 1.4967 | -4.2558 |
| 2019-nCoV | Thr | 135 | 1 | 1.5033 | -5.4066 |
| 2019-nCoV | Gly | 138 | 1 | 2.5685 | -4.7547 |
| 2019-nCoV | Lie | 136 | 1 | 1.9035 | -4.9637 |
| 2019-nCoV | Ser | 139 | 1 | 2.8756 | -5.1167 |
| 2019-nCoV | Ser | 139 | 1 | 3.1103 | -4.7890 |
| 2019-nCoV | His | 172 | 1 | 2.0245 | -6.5234 |
| 2019-nCoV | His | 172 | 1 | 2.5439 | -5.2279 |
| 2019-nCoV | His | 172 | 1 | 2.0632 | -4.1191 |
| 2019-nCoV | His | 172 | 1 | 2.1195 | -5.5631 |
Fig. 9Steric interactions between the Atazanavir and Coronavirus 2019-nCoV.
Fig. 10Molecular docking of the Atazanavir to Coronavirus 2019-nCoV.